245 related articles for article (PubMed ID: 18221168)
1. Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.
Burkhardt O; Pletz MW; Mertgen CP; Welte T
Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):123-30. PubMed ID: 18221168
[TBL] [Abstract][Full Text] [Related]
2. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
4. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
[TBL] [Abstract][Full Text] [Related]
5. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
[TBL] [Abstract][Full Text] [Related]
6. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
7. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
8. Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.
Wang Y; Zou Y; Xie J; Wang T; Zheng X; He H; Dong W; Xing J; Dong Y
Eur J Clin Pharmacol; 2015 Jan; 71(1):107-15. PubMed ID: 25355172
[TBL] [Abstract][Full Text] [Related]
9. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Chavanet P
Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896
[TBL] [Abstract][Full Text] [Related]
10. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
[TBL] [Abstract][Full Text] [Related]
11. Linezolid: pharmacokinetic characteristics and clinical studies.
Bouza E; Muñoz P
Clin Microbiol Infect; 2001; 7 Suppl 4():75-82. PubMed ID: 11688537
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of linezolid to the treatment of nosocomial pneumonia].
Gouin F
Presse Med; 2003 Apr; 32(13 Pt 2):S13-6. PubMed ID: 12754444
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Pletz MW; Burkhardt O; Welte T
Eur J Med Res; 2010 Nov; 15(12):507-13. PubMed ID: 21163725
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
Noskin GA
Ann Acad Med Singap; 2001 May; 30(3):320-31. PubMed ID: 11455748
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus.
Machado AR; Arns Cda C; Follador W; Guerra A
Braz J Infect Dis; 2005 Jun; 9(3):191-200. PubMed ID: 16224625
[TBL] [Abstract][Full Text] [Related]
16. Linezolid in children: recent patents and advances.
Velissariou IM
Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):73-7. PubMed ID: 18221164
[TBL] [Abstract][Full Text] [Related]
17. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Daniel Mullins C; Kuznik A; Shaya FT; Obeidat NA; Levine AR; Liu LZ; Wong W
Clin Ther; 2006 Aug; 28(8):1184-1198. PubMed ID: 16982296
[TBL] [Abstract][Full Text] [Related]
19. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
Smith RL; Evans HL; Chong TW; McElearney ST; Hedrick TL; Swenson BR; Scheld WM; Pruett TL; Sawyer RG
Surg Infect (Larchmt); 2008 Aug; 9(4):423-31. PubMed ID: 18759679
[TBL] [Abstract][Full Text] [Related]
20. Linezolid resistance in a clinical isolate of Staphylococcus aureus.
Tsiodras S; Gold HS; Sakoulas G; Eliopoulos GM; Wennersten C; Venkataraman L; Moellering RC; Ferraro MJ
Lancet; 2001 Jul; 358(9277):207-8. PubMed ID: 11476839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
